Canakinumab is a medication used to treat various inflammatory conditions, including systemic juvenile idiopathic arthritis and gout. It works by inhibiting a protein called interleukin-1 beta, which plays a key role in the inflammatory response. By blocking this protein, canakinumab helps reduce inflammation and alleviate symptoms associated with these diseases. This drug is administered through an injection, typically given every few weeks, depending on the condition being treated. Canakinumab is part of a class of medications known as biologics, which are derived from living organisms and target specific components of the immune system to provide relief from chronic inflammation.